Inqovi 35 MG-100 MG tablet UU 5S
Ended Awarded
- Contract number
- SPE2DB25FR9WF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,477
Award facts
- Contract value 100% obligated
- $20,477.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,477.44 to AmerisourceBergen Drug Corp for INQOVI (decitabine and cedazuridine) 35 mg-100 mg tablets on September 25, 2025, with completion expected by October 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, a $1 billion prime vehicle designated SPE2DX that extends through December 2026.
AmerisourceBergen serves as a critical federal pharmaceutical vendor, supplying a comprehensive range of medications and medical supplies to support military healthcare systems and other government agencies. The company's DLA indefinite delivery contract enables flexible procurement of specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs globally. This delivery order for INQOVI, a drug used in hematologic malignancy treatment, exemplifies the company's role in providing specialized pharmaceutical products to federal healthcare systems through open, competitive procurement processes.
Quick answers
Who was awarded contract SPE2DB25FR9WF?
SPE2DB25FR9WF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FR9WF worth?
The government has obligated $20,477 on SPE2DB25FR9WF.
Is contract SPE2DB25FR9WF an order under another contract?
Yes. SPE2DB25FR9WF is a delivery order under SPE2DB22D2103, an indefinite delivery contract.
Was contract SPE2DB25FR9WF competed?
The extent of competition for SPE2DB25FR9WF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award